Elecsys hepatitis B surface antigen quantitative assay: Performance evaluation and correlation with hepatitis B virus DNA during 96 weeks of follow-up in chronic hepatitis B patients

Annals of Laboratory Medicine

Volumn 32, Issue 6, 2012, Pages 420-425

  Lee, Hyun Ji ^a   Kim, Shine Young ^a   Lee, Sun Min ^a   Heo, Jeong ^b   Kim, Hyung Hoi ^a   Chang, Chulhun L ^a   Lee, Eun Yup ^a   Son, Han Chul ^a  

^a Pusan National University School of Medicine   (South Korea)

^b Pusan National University School of Medicine   (South Korea)

Author keywords

Chronic hepatitis B; HBsAg; Hepatitis B virus; Quantification

Indexed keywords

EID: 84868539805     PISSN: 22343806     EISSN: 22343814     Source Type: Journal    
DOI: 10.3343/alm.2012.32.6.420     Document Type: Article

References (24)

1. Lin LY, Wong VW, Zhou HJ, Chan HY, Gui HL, Guo SM, et al. Relationship between serum hepatitis B virus DNA and surface antigen with covalently closed circular DNA in HBeAgnegative patients. J Med Virol 2010;82:1494-500.
2. Lee WM. Hepatitis B virus infection. N Engl J Med 1997;337:1733-45. (Pubitemid 27527771)
3. Nguyen T, Thompson AJ, Bowden S, Croagh C, Bell S, Desmond PV, et al. Hepatitis B surface antigen levels during the natural history of chronic hepatitis B: a perspective on Asia. J Hepatol 2010;52:508-13.
4. Jaroszewicz J, Calle Serrano B, Wursthorn K, Deterding K, Schlue J, Raupach R, et al. Hepatitis B surface antigen (HBsAg) levels in the natural history of hepatitis B virus (HBV)-infection: a European perspective. J Hepatol 2010;52:514-22.
5. Thompson AJ, Nguyen T, Iser D, Ayres A, Jackson K, Littlejohn M, et al. Serum hepatitis B surface antigen and hepatitis B e antigen titers: disease phase influences correlation with viral load and intrahepatic hepatitis B virus markers. Hepatology 2010;51:1933-44.
6. Sonneveld MJ, Rijckborst V, Boucher CA, Zwang L, Beersma MF, Hansen BE, et al. A comparison of two assays for quantification of Hepatitis B surface Antigen in patients with chronic hepatitis B. J Clin Virol 2011; 51:175-8.
7. Wursthorn K, Jaroszewicz J, Zacher BJ, Darnedde M, Raupach R, Mederacke I, et al. Correlation between the Elecsys HBsAg II assay and the Architect assay for the quantification of hepatitis B surface antigen (HBsAg) in the serum. J Clin Virol 2011;50:292-6.
8. National Committee for Clinical Laboratory Standards. Evaluation of precision performance of puantitative measurement methods: Approved guideline, EP5-A2. Wayne, PA: National Committee for Clinical Laboratory Standards, 2004.
9. Tholen DW. Evaluation of linearity using the newly approved NCCLS EP6-A protocol. Clin Lab News 2004;30:10-2.
10. National Committee for Clinical Laboratory Standards. Preliminary evaluation of quantitative clinical laboratory methods: Approved guideline, EP10-A2. Second edition. Wayne, PA: National Committee for Clinical Laboratory Standards, 2002.
11. National Committee for Clinical Laboratory Standards. Protocols for determination of limits of detection and limits of quantitation: Approved guideline EP17-A. Wayne, PA: National Committee for Clinical and Laboratory Standards, 2004.
12. Glass DC and Gray CN. Estimating mean exposures from censored data: exposure to benzene in the Australian petroleum industry. Ann Occup Hyg 2001;45:275-82.
13. Chan HL, Thompson A, Martinot-Peignoux M, Piratvisuth T, Cornberg M, Brunetto MR, et al. Hepatitis B surface antigen quantification: why and how to use it in 2011-a core group report. J Hepatol 2011;55:1121-31.
14. Moucari R and Marcellin P. Quantification of hepatitis B surface antigen: a new concept for the management of chronic hepatitis B. Liver Int 2011;31(S1):122-8.
15. Deguchi M, Yamashita N, Kagita M, Asari S, Iwatani Y, Tsuchida T, et al. Quantitation of hepatitis B surface antigen by an automated chemiluminescent microparticle immunoassay. J Virol Methods 2004;115:217-22. (Pubitemid 37506037)
16. Ozaras R, Tabak F, Tahan V, Ozturk R, Akin H, Mert A, et al. Correlation of quantitative assay of HBsAg and HBV DNA levels during chronic HBV treatment. Dig Dis Sci 2008;53:2995-8.
17. Weigand J, Wedemeyer H, Finger A, Heidrich B, Rosenau J, Michel G, et al. A decline in hepatitis B virus surface antigen (hbsag) predicts clearance, but does not correlate with quantitative hbeag or HBV DNA levels. Antivir Ther 2008;13:547-54. (Pubitemid 352016717)
18. Chen J, Wang Z, Guo Y, Peng J, Sun J, Ahmed CS, et al. Serum HBsAg changes in HBeAg positive chronic hepatitis B patients with continuous viral load reductions during treatment with adefovir or peg-interferon-alpha-2a. Antiviral Res 2009;81:88-91.
19. Moucari R, Mackiewicz V, Lada O, Ripault M P, Castelnau C, Martinot-Peignoux M, et al. Early serum HBsAg drop: a strong predictor of sustained virological response to pegylated interferon alfa-2a in HBeAgnegative patients. Hepatology 2009;49:1151-7.
20. Cho YK and Song BC. New insight for HBV DNA and HBsAg quantitation during antiviral therapy in patients with chronic hepatitis B. Korean J Gastroenterol 2011;57:144-9.
21. Chan HL, Wong VW, Tse AM, Tse CH, Chim AM, Chan HY, et al. Serum hepatitis B surface antigen quantitation can reflect hepatitis B virus in the liver and predict treatment response. Clin Gastroenterol Hepatol 2007;5:1462-8. (Pubitemid 350181604)
22. Piratvisuth T, Marcellin P, Popescu M, Kapprell HP, Rothe V, Lu ZM. Hepatitis B surface antigen: association with sustained response to peginterferon alfa-2a in hepatitis B e antigen-positive patients. Hepatology Int 2011 [Epub ahead of print].
23. Lee MH, Lee DM, Kim SS, Cheong JY, Cho SW. Correlation of serum hepatitis B surface antigen level with response to entecavir in naïve patients with chronic hepatitis B. J Med Virol 2011;83:1178-86.
24. Cai W, Xie Q, An B, Wang H, Zhou X, Zhao G, et al. On-treatment serum HBsAg level is predictive of sustained off-treatment virologic response to telbivudine in HBeAg-positive chronic hepatitis B patients. J Clin Virol 2010;48:22-6.